BALCX
Price
$40.69
Change
+$0.10 (+0.25%)
Updated
Jun 2 closing price
Net Assets
278.87B
SIBLX
Price
$30.79
Change
-$0.13 (-0.42%)
Updated
Jun 2 closing price
Net Assets
1.01B
Interact to see
Advertisement

BALCX vs SIBLX

Header iconBALCX vs SIBLX Comparison
Open Charts BALCX vs SIBLXBanner chart's image
BALCX vs SIBLX Comparison Chart in %
View a ticker or compare two or three
VS
BALCX vs. SIBLX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALCX is a Hold and SIBLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALCX has more cash in the bank: 279B vs. SIBLX (1.01B). SIBLX pays higher dividends than BALCX: SIBLX (1.49) vs BALCX (1.16). BALCX was incepted earlier than SIBLX: BALCX (25 years) vs SIBLX (19 years). BALCX (1.30) is less costly to investors than SIBLX (0.77). SIBLX is a more actively managed with annual turnover of: 82.00 vs. BALCX (50.00). BALCX has a lower initial minimum investment than SIBLX: BALCX (250) vs SIBLX (2500). BALCX annual gain was more profitable for investors over the last year : 16.84 vs. SIBLX (12.64). BALCX (31.27) and SIBLX (31.18) have equivalent 5 years return.
BALCXSIBLXBALCX / SIBLX
Total Expense Ratio1.300.77169%
Annual Report Gross Expense Ratio1.300.77169%
Fund Existence25 years19 years-
Gain YTD9.3723.962237%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets279B1.01B27,651%
Annual Yield % from dividends1.161.4978%
Returns for 1 year16.8412.64133%
Returns for 3 years42.3238.10111%
Returns for 5 years31.2731.18100%
Returns for 10 years77.1784.3591%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSMUX27.23N/A
N/A
Carillon Scout Mid Cap R-6
TRZIX20.29N/A
N/A
T. Rowe Price Small-Cap Index Z
NWFFX107.92N/A
N/A
American Funds New World F1
BPLEX11.76N/A
N/A
Boston Partners Long/Short Equity Inv
LYRAX32.25N/A
N/A
Lyrical US Value Equity A